News

Sales of Olainfarm Increase by 55% in January

on February 15, 2013

Preliminary consolidated results of JSC Olainfarm for January 2013 show that sales have increased by 55% compared to the same period of last year and have reached 5.47 million lats (7.78 million euros). Major sales increases were achieved in Belarus, where sales grew by 110%, Russia (by 105%) and Latvia, where sales grew by 48%.  Biggest sales markets of JSC Olainfarm in January 2013 were Russia, Latvia and Ukraine.

January 2013, consolidated results Share in total sales Changes to January 2012
Russia 50% 105%
Latvia 18% 48%
Ukraine 14% -22%
Belarus 7% 110%
UK 5% NA
Uzbekistan 2% NA
Czech Republic 1% NA
Italy <1% NA
Kazakhstan <1% NA
Moldova <1% NA
Other 1% -79%
Total 100% 55%

 

Sales of pharmacies owned by JSC Olainfarm in January 2013 was 0.74 million lats (1.05 million euros).

According to preliminary unconsolidated results of JSC Olainfarm, the sales during January 2013 were 4.92 million lats (7 million euros), which represents an increase by 63% compared to similar period a year ago. Most rapid sales increases were achieved in Latvia (by 165%), Belarus (by 110%) and Russia, where sales grew by 105%. According to unconsolidated results the main sales markets of JSC Olainfarm in January 2013 were Russia, Ukraine, Latvia and Belarus.

January 2013, unconsolidated results Share in total sales Changes to January 2012
Russia 55% 105%
Ukraine 16% -22%
Latvia 9% 165%
Belarus 8% 110%
UK 6% NA
Uzbekistan 3% NA
Czech Republic 1% NA
Italy <1% NA
Kazakhstan <1% NA
Moldova <1% NA
Other 1% -79%
Total 100% 63%

 

Although no sales targets for 2013 are formally approved yet, for planning purposes management is using the target of 50 million lats (71.1 million euros) for unconsolidated sales and 57 million lats (81.1 million euros) for consolidated sales. According to these preliminary results, during the month of January the company has made 9.8% of annual unconsolidated sales target and 9.6% of annual consolidated sales target.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:

Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv

SigitaSales of Olainfarm Increase by 55% in January